Nutritionally variant streptococci: Difference between revisions
From IDWiki
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
No edit summary |
||
| Line 12: | Line 12: | ||
* [[Subacute bacterial endocarditis]] is the most well-known disease association |
* [[Subacute bacterial endocarditis]] is the most well-known disease association |
||
| + | == Management == |
||
| + | |||
| + | * Susceptibilities shown below are from one small study[[CiteRef::kanamoto2018an]] |
||
| + | |||
| + | {| class="wikitable" |
||
| + | !Antibiotic |
||
| + | ![[Abiotrophia defectiva]] |
||
| + | ![[Granulicatella adiacens]] |
||
| + | ![[Granulicatella elegans]] |
||
| + | |- |
||
| + | |Penicillin |
||
| + | |57% |
||
| + | |82% |
||
| + | |100% |
||
| + | |- |
||
| + | |Ampicillin |
||
| + | |86% |
||
| + | |100% |
||
| + | |100% |
||
| + | |- |
||
| + | |Piperacillin |
||
| + | |0% |
||
| + | |53% |
||
| + | |100% |
||
| + | |- |
||
| + | |Cefazolin |
||
| + | |29% |
||
| + | |88% |
||
| + | |100% |
||
| + | |- |
||
| + | |Ceftriaxone |
||
| + | |100% |
||
| + | |76% |
||
| + | |100% |
||
| + | |- |
||
| + | |Ceftazidime |
||
| + | |0% |
||
| + | |0% |
||
| + | |50% |
||
| + | |- |
||
| + | |Imipenem |
||
| + | |100% |
||
| + | |100% |
||
| + | |100% |
||
| + | |- |
||
| + | |Gentamicin |
||
| + | |0% |
||
| + | |0% |
||
| + | |0% |
||
| + | |- |
||
| + | |Ciprofloxacin |
||
| + | |100% |
||
| + | |18% |
||
| + | |17% |
||
| + | |- |
||
| + | |Minocycline |
||
| + | |57% |
||
| + | |94% |
||
| + | |100% |
||
| + | |- |
||
| + | |Vancomycin |
||
| + | |100% |
||
| + | |100% |
||
| + | |83% |
||
| + | |- |
||
| + | |TMP-SMX |
||
| + | |14% |
||
| + | |0% |
||
| + | |17% |
||
| + | |} |
||
[[Category:Gram-positive cocci]] |
[[Category:Gram-positive cocci]] |
||
Revision as of 15:17, 11 March 2022
Background
- Require pyridoxine (vitamin B6) supplementation to group
- Also called pyridoxal-dependent or stalliting streptococci
Organisms
Clinical Manifestations
- Subacute bacterial endocarditis is the most well-known disease association
Management
- Susceptibilities shown below are from one small study1
| Antibiotic | Abiotrophia defectiva | Granulicatella adiacens | Granulicatella elegans |
|---|---|---|---|
| Penicillin | 57% | 82% | 100% |
| Ampicillin | 86% | 100% | 100% |
| Piperacillin | 0% | 53% | 100% |
| Cefazolin | 29% | 88% | 100% |
| Ceftriaxone | 100% | 76% | 100% |
| Ceftazidime | 0% | 0% | 50% |
| Imipenem | 100% | 100% | 100% |
| Gentamicin | 0% | 0% | 0% |
| Ciprofloxacin | 100% | 18% | 17% |
| Minocycline | 57% | 94% | 100% |
| Vancomycin | 100% | 100% | 83% |
| TMP-SMX | 14% | 0% | 17% |
References
- ^ Taisei Kanamoto, Shigemi Terakubo, Hideki Nakashima. Antimicrobial Susceptibilities of Oral Isolates of Abiotrophia and Granulicatella According to the Consensus Guidelines for Fastidious Bacteria. Medicines. 2018;5(4):129. doi:10.3390/medicines5040129.
